BAXTER INTERNATIONAL INC (1BAX.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BAX - US0718131099 - Common Stock
30.905 EUR
+0.18 (+0.57%)
1BAX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 64 industry peers in the Health Care Equipment & Supplies industry. 1BAX has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
1BAX had positive earnings in the past year.
In the past year 1BAX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1BAX reported negative net income in multiple years.
Each year in the past 5 years 1BAX had a positive operating cash flow.
1.2 Ratios
1BAX's Return On Assets of -2.52% is in line compared to the rest of the industry. 1BAX outperforms 40.35% of its industry peers.
With a Return On Equity value of -9.32%, 1BAX perfoms like the industry average, outperforming 40.35% of the companies in the same industry.
1BAX's Return On Invested Capital of 3.45% is in line compared to the rest of the industry. 1BAX outperforms 49.12% of its industry peers.
1BAX had an Average Return On Invested Capital over the past 3 years of 3.20%. This is significantly below the industry average of 9.33%.
The 3 year average ROIC (3.20%) for 1BAX is below the current ROIC(3.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROIC | 3.45% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1.3 Margins
1BAX has a Operating Margin (7.67%) which is in line with its industry peers.
In the last couple of years the Operating Margin of 1BAX has declined.
1BAX has a Gross Margin of 38.01%. This is in the lower half of the industry: 1BAX underperforms 71.93% of its industry peers.
1BAX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% |
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1BAX is destroying value.
The number of shares outstanding for 1BAX has been increased compared to 1 year ago.
Compared to 5 years ago, 1BAX has more shares outstanding
1BAX has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.10 indicates that 1BAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
1BAX has a Altman-Z score (2.10) which is comparable to the rest of the industry.
The Debt to FCF ratio of 1BAX is 22.91, which is on the high side as it means it would take 1BAX, 22.91 years of fcf income to pay off all of its debts.
1BAX's Debt to FCF ratio of 22.91 is in line compared to the rest of the industry. 1BAX outperforms 50.88% of its industry peers.
A Debt/Equity ratio of 1.79 is on the high side and indicates that 1BAX has dependencies on debt financing.
1BAX has a Debt to Equity ratio of 1.79. This is amonst the worse of the industry: 1BAX underperforms 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.53
WACC6.49%
2.3 Liquidity
A Current Ratio of 1.36 indicates that 1BAX should not have too much problems paying its short term obligations.
The Current ratio of 1BAX (1.36) is comparable to the rest of the industry.
A Quick Ratio of 1.05 indicates that 1BAX should not have too much problems paying its short term obligations.
1BAX has a Quick ratio (1.05) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.37% over the past year.
The Earnings Per Share has been decreasing by -4.21% on average over the past years.
1BAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.21%.
Measured over the past years, 1BAX shows a decrease in Revenue. The Revenue has been decreasing by -1.31% on average per year.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
3.2 Future
1BAX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.87% yearly.
1BAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.61, which indicates a correct valuation of 1BAX.
1BAX's Price/Earnings ratio is rather cheap when compared to the industry. 1BAX is cheaper than 89.47% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. 1BAX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 13.58, which indicates a correct valuation of 1BAX.
Based on the Price/Forward Earnings ratio, 1BAX is valued a bit cheaper than the industry average as 75.44% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.59. 1BAX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 |
4.2 Price Multiples
78.95% of the companies in the same industry are more expensive than 1BAX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1BAX indicates a somewhat cheap valuation: 1BAX is cheaper than 73.68% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.59 | ||
| EV/EBITDA | 13.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.17%, 1BAX has a reasonable but not impressive dividend return.
1BAX's Dividend Yield is rather good when compared to the industry average which is at 2.16. 1BAX pays more dividend than 80.70% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, 1BAX has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
On average, the dividend of 1BAX grows each year by 6.89%, which is quite nice.
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1BAX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
1BAX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
BIT:1BAX (3/26/2025, 7:00:00 PM)
30.905
+0.18 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap15.85B
Revenue(TTM)12.86B
Net Income(TTM)-649.00M
Analysts68.18
Price Target35.44 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 | ||
| P/S | 1.36 | ||
| P/FCF | 30.59 | ||
| P/OCF | 17.2 | ||
| P/B | 2.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.5 |
EPS(TTM)2.45
EY7.93%
EPS(NY)2.28
Fwd EY7.36%
FCF(TTM)1.01
FCFY3.27%
OCF(TTM)1.8
OCFY5.81%
SpS22.67
BVpS12.28
TBVpS-6.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROCE | 5.12% | ||
| ROIC | 3.45% | ||
| ROICexc | 3.76% | ||
| ROICexgc | 8.07% | ||
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% | ||
| FCFM | 4.46% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexgc growth 3Y-30.34%
ROICexgc growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Debt/EBITDA | 6.3 | ||
| Cap/Depr | 44.73% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | 4.42 | ||
| Cash Conversion | 51.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.1 |
F-Score3
WACC6.49%
ROIC/WACC0.53
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%
BAXTER INTERNATIONAL INC / 1BAX.MI FAQ
What is the ChartMill fundamental rating of BAXTER INTERNATIONAL INC (1BAX.MI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI.
What is the valuation status for 1BAX stock?
ChartMill assigns a valuation rating of 5 / 10 to BAXTER INTERNATIONAL INC (1BAX.MI). This can be considered as Fairly Valued.
What is the profitability of 1BAX stock?
BAXTER INTERNATIONAL INC (1BAX.MI) has a profitability rating of 3 / 10.
What are the PE and PB ratios of BAXTER INTERNATIONAL INC (1BAX.MI) stock?
The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 12.61 and the Price/Book (PB) ratio is 2.52.
How financially healthy is BAXTER INTERNATIONAL INC?
The financial health rating of BAXTER INTERNATIONAL INC (1BAX.MI) is 3 / 10.